Biomensio is revolutionizing analytics through its Diagnostics-as-a-Service Platform. The platform consists of a fully digital handheld reader, multianalyte fluid cartridges, and a cloud-based analytics service powered by professional services team. Our initial application areas of interest are point-of-need applications including the detection of drug abuse in saliva, as well as food and milk safety. At the heart of our DXaaS platform is our highly scalable Rapid Multi-Analyte Sensor, a miniaturized micro-array platform integrated into a cost-efficient fluidic cartridge facilitating the fast development of new bio-screening applications for on-site testing. The pixels of the sensor are functionalized with a biologically active layer, like antibodies or DNA, enabling unique label-free capabilities for screening multiple biological targets from the same liquid sample in one step. Biomensio technology is scalable and robust – neither optics nor moving parts are required. Our capability to meet the high quality and volume expectations of the market is based on utilizing existing and proven easily scalable high volume production technologies.